190 related articles for article (PubMed ID: 31287662)
21. Redispersion of cryoaggregated gold nanoparticle by means of laser irradiation and effect on biological interactions.
Mishra A; Shaikh S; Kumar A
Nanotechnology; 2020 Oct; 31(43):435601. PubMed ID: 32619991
[TBL] [Abstract][Full Text] [Related]
22. CW-laser-induced morphological changes of a single gold nanoparticle on glass: observation of surface evaporation.
Setoura K; Okada Y; Hashimoto S
Phys Chem Chem Phys; 2014 Dec; 16(48):26938-45. PubMed ID: 25377431
[TBL] [Abstract][Full Text] [Related]
23. Plasmonic nanobubbles as transient vapor nanobubbles generated around plasmonic nanoparticles.
Lukianova-Hleb E; Hu Y; Latterini L; Tarpani L; Lee S; Drezek RA; Hafner JH; Lapotko DO
ACS Nano; 2010 Apr; 4(4):2109-23. PubMed ID: 20307085
[TBL] [Abstract][Full Text] [Related]
24. Treatment of vitreous floaters with neodymium YAG laser.
Tsai WF; Chen YC; Su CY
Br J Ophthalmol; 1993 Aug; 77(8):485-8. PubMed ID: 8025044
[TBL] [Abstract][Full Text] [Related]
25. Light Scattering by Vitreous of Humans With Vision Degrading Myodesopsia From Floaters.
Paniagua-Diaz AM; Nguyen JH; Artal P; Gui W; Sebag J
Invest Ophthalmol Vis Sci; 2024 May; 65(5):20. PubMed ID: 38727692
[TBL] [Abstract][Full Text] [Related]
26. New Terminology and Methodology for the Assessment of the Vitreous, Its Floaters and Opacities, and Their Effect on Vision: Standardized and Kinetic Anatomical and Functional Testing of Vitreous Floaters and Opacities (SK VFO Test).
Stanga PE; Valentin Bravo FJ; Reinstein UI; Stanga SFE; Marshall J; Archer TJ; Reinstein DZ
Ophthalmic Surg Lasers Imaging Retina; 2023 May; 54(5):306-315. PubMed ID: 37184989
[TBL] [Abstract][Full Text] [Related]
27. Vitrectomy for vitreous opacities and macular pucker in Gaucher disease.
Rapizzi E; Vannozzi L; Borgioli V; Giansanti F; Murro V; Sodi A; Menchini U
Eur J Ophthalmol; 2011; 21(3):340-2. PubMed ID: 20954144
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters].
Shaimova VA; Shaimov TB; Shaimov RB; Galin AY; Goloshchapova ZA; Ryzhkov PK; Fomin AV
Vestn Oftalmol; 2018; 134(1):56-62. PubMed ID: 29543200
[TBL] [Abstract][Full Text] [Related]
29. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment.
Ieki Y; Kiryu J; Kita M; Tanabe T; Tsujikawa A; Yamashiro K; Miyamoto N; Miura S; Honda Y
Ocul Immunol Inflamm; 2004 Mar; 12(1):35-43. PubMed ID: 15209462
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters.
Luo J; An X; Kuang Y
J Int Med Res; 2018 Nov; 46(11):4465-4471. PubMed ID: 30200800
[TBL] [Abstract][Full Text] [Related]
31. Asteroid hyalosis-a comprehensive review.
Khoshnevis M; Rosen S; Sebag J
Surv Ophthalmol; 2019; 64(4):452-462. PubMed ID: 30707924
[TBL] [Abstract][Full Text] [Related]
32. Selective Targeting and Restrictive Damage for Nonspecific Cells by Pulsed Laser-Activated Hyaluronan-Gold Nanoparticles.
Rau LR; Tsao SW; Liaw JW; Tsai SW
Biomacromolecules; 2016 Aug; 17(8):2514-21. PubMed ID: 27439142
[TBL] [Abstract][Full Text] [Related]
33. ["Floaterectomy"--pars-plana-vitrectomy for vitreous opacities].
Weber-Varszegi V; Senn P; Becht CN; Schmid MK
Klin Monbl Augenheilkd; 2008 May; 225(5):366-9. PubMed ID: 18454374
[TBL] [Abstract][Full Text] [Related]
34. Vitrectomy for vitreous floaters: analysis of the benefits and risks.
Sommerville DN
Curr Opin Ophthalmol; 2015 May; 26(3):173-6. PubMed ID: 25784107
[TBL] [Abstract][Full Text] [Related]
35. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy.
Koga T; Ando E; Hirata A; Fukushima M; Kimura A; Ando Y; Negi A; Tanihara H
Am J Ophthalmol; 2003 Feb; 135(2):188-93. PubMed ID: 12566023
[TBL] [Abstract][Full Text] [Related]
36. Transient photothermal spectra of plasmonic nanobubbles.
Lukianova-Hleb EY; Sassaroli E; Jones A; Lapotko DO
Langmuir; 2012 Mar; 28(10):4858-66. PubMed ID: 22339620
[TBL] [Abstract][Full Text] [Related]
37. RE-INTERVENTION IN DE NOVO VITREOUS OPACITIES AFTER PARS PLANA VITRECTOMY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TTR VAL30METPORTUGUESE PATIENTS.
Ferreira NN; Cunha Dias DA; Afonso Carvalho RP; Pardal Monteiro Coelho MT
Retin Cases Brief Rep; 2019 Summer; 13(3):273-278. PubMed ID: 28333852
[TBL] [Abstract][Full Text] [Related]
38. EGF Functionalized Polymer-Coated Gold Nanoparticles Promote EGF Photostability and EGFR Internalization for Photothermal Therapy.
Silva CO; Petersen SB; Reis CP; Rijo P; Molpeceres J; Fernandes AS; Gonçalves O; Gomes AC; Correia I; Vorum H; Neves-Petersen MT
PLoS One; 2016; 11(10):e0165419. PubMed ID: 27788212
[TBL] [Abstract][Full Text] [Related]
39. [Vitrectomy via pars plana. A histological study and an analysis of clinical results (author's transl)].
Gnad HD
Wien Klin Wochenschr Suppl; 1980; 108():1-22. PubMed ID: 6769257
[TBL] [Abstract][Full Text] [Related]
40. Labeled gold nanoparticles immobilized at smooth metallic substrates: systematic investigation of surface plasmon resonance and surface-enhanced Raman scattering.
Driskell JD; Lipert RJ; Porter MD
J Phys Chem B; 2006 Sep; 110(35):17444-51. PubMed ID: 16942083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
